On 2026-06-17, Odyssey Therapeutics, Inc. (ODTX) announced earnings per share of -6.77 for the fiscal quarter ending 2026-03-31, missing the average analyst estimate of -1.31.

The next expected annoucement date for quarterly earnings is 2026-09-16, with an average estimated earnings per share of -0.89 for the fiscal quarter ending 2026-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.